Product
Recombinant human activated coagulation factor VIII
Aliases
Recombinant human activated coagulation factor VIII for injection
1 clinical trial
1 indication
Indication
Hemophilia AClinical trial
A Phase III Clinical Study Evaluating the Efficacy and Safety of On-demand Treatment and Perioperative Replacement Therapy With Recombinant Human Coagulation Factor VIII for Injection in Treated Severe Hemophilia AStatus: Not yet recruiting, Estimated PCD: 2025-04-01